Regeneron warned its popular antibody cocktail used to treat high-risk cases of COVID-19 may not be as effective against the new Omicron variant. The New York-based pharmaceutical company said ...

A single dose of Regeneron’s antibody cocktail—administered via four injections—cut the risk of contracting Covid-19 by 81.6% up to eight months after it’s given, the New York-based ...

Biotech giant Regeneron has claimed that its antibody cocktail reduces the risk of COVID-19 infection by nearly 82% for eight months.

Regeneron Pharmaceuticals said Tuesday that its antibody cocktail, which is used widely to treat COVID-19 patients, may be less effective against the Omicron variant.

An expert WHO panel recommended Regeneron’s antibody cocktail (marketed as REGEN-COV in the U.S.) for patients at risk of developing severe Covid-19 and patients with severe or critical Covid-19 ...

Regeneron’s antibody cocktail cut the risk of contracting COVID-19 by 81.6 percent in the two to eight months after the cocktail’s administration, the pharmaceutical company announced on Monday.

Regeneron Pharmaceuticals and AstraZeneca, makers of monoclonal antibody cocktails used as treatment for many coronavirus patients who have not been vaccinated, announced contrasting data Thursday ...

There hasn’t been any direct data testing yet to evaluate the omicron variant’s resistance to coronavirus cocktails and vaccines, but Regeneron wants to start studying the latest variant. The ...

Regeneron Pharmaceuticals REGN’s antibody cocktail for COVID-19, REGEN-COV (casirivimab and imdevimab) is now being recommended for treatment by the Governor of Florida as cases continue to surge.

Regeneron's COVID-19 antibody cocktail, casirivimab and imdevimab, reduced the risk of death among hospitalized patients in a phase 3 trial, the drugmaker said June 16. Skip to main content BHR ...

Shares of Regeneron Pharmaceuticals Inc. gained 3.7% in premarket trading on Monday after the company said four subcutaneous injections of its monoclonal antibody treatment protected unvaccinated ...